| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |